Changes in calmodulin concentration and cyclic 3′,5′-nucleotide phosphodiesterase activity in skeletal muscle of hyper- and hypothyroid rats

in Journal of Endocrinology
Authors:
T Mano
Search for other papers by T Mano in
Current site
Google Scholar
PubMed
Close
,
K Iwase
Search for other papers by K Iwase in
Current site
Google Scholar
PubMed
Close
,
I Yoshimochi
Search for other papers by I Yoshimochi in
Current site
Google Scholar
PubMed
Close
,
Y Sawai
Search for other papers by Y Sawai in
Current site
Google Scholar
PubMed
Close
,
N Oda
Search for other papers by N Oda in
Current site
Google Scholar
PubMed
Close
,
Y Nishida
Search for other papers by Y Nishida in
Current site
Google Scholar
PubMed
Close
,
T Mokuno
Search for other papers by T Mokuno in
Current site
Google Scholar
PubMed
Close
,
M Kotake
Search for other papers by M Kotake in
Current site
Google Scholar
PubMed
Close
,
A Nakai
Search for other papers by A Nakai in
Current site
Google Scholar
PubMed
Close
,
N Hayakawa
Search for other papers by N Hayakawa in
Current site
Google Scholar
PubMed
Close
,
R Kato
Search for other papers by R Kato in
Current site
Google Scholar
PubMed
Close
,
A Nagasaka
Search for other papers by A Nagasaka in
Current site
Google Scholar
PubMed
Close
, and
H Hidaka
Search for other papers by H Hidaka in
Current site
Google Scholar
PubMed
Close
Restricted access
Rent on DeepDyve

Sign up for journal news

Abstract

Hyper- and hypothyroid states occasionally induce skeletal muscle dysfunction i.e. periodic paralysis and thyroid myopathy. The etiology of these diseases remains unclear, but several findings suggest that the catecholamine-β-receptor-cAMP system or other messenger systems are disturbed in these diseases. In this context, we evaluated changes in the cyclic 3′,5′-nucleotide metabolic enzyme, cyclic 3′,5′-nucleotide phosphodiesterase (PDE) and calmodulin concentrations in skeletal muscles of hyper- and hypothyroid rats.

Activities of cyclic AMP-PDE were low in skeletal muscle both from hyper- and hypothyroid rats, and calmodulin concentration was high in hyperthyroid and low in hypothyroid rats, as compared with normal rats. DE-52 column chromatographic analysis showed that the cGMP hydrolytic activity in peak I and the cAMP hydrolytic activity in peak II were decreased in hypothyroid rats, whereas cAMP hydrolytic activity in peak III was unchanged. The cAMP hydrolytic activity in peak III was decreased in hyperthyroid rats, but the activities in peaks I and II were unchanged. These findings indicate that cAMP and calmodulin may have some role in skeletal muscle function in the hyperthyroid state, and that cAMP and calmodulin-dependent metabolism may be suppressed in the hypothyroid state.

Journal of Endocrinology (1995) 146, 287–292